AbbVie Inc (NYSE:ABBV)

60.29
Data as of Oct 24
 +0.77 / +1.29%
Today’s Change
45.50
Today|||52-Week Range
60.41
+14.16%
Year-to-Date
Shire and AstraZeneca show standalone strength
Oct 24 / FT.com
First Detailed Look at Celgene Crohn's Disease Pill Impresses
Oct 20 / TheStreet.com
Revlimid: Celgene Corporation's Gift That Keeps on Giving
Oct 23 / MotleyFool.com
What Johnson & Johnson Can Tell Us about Gilead Sciences, inc. Stock
Oct 20 / MotleyFool.com
Mylan tweaks $5bn 'inversion' deal
Oct 22 / FT.com
Benzinga's Weekend M&A Chatter
Oct 19 / Benzinga
Biotech Stock Roundup: AbbVie Calls off Shire Acquisition, Will Amgen Consider Breaku...
Oct 22 / Zacks.com
Long-term reforms of US tax system required to stop 'deserters'
Oct 19 / FT.com
Third Point's Daniel Loeb Tells Amgen it's Time to Break up
Oct 22 / TheStreet.com
M&A deal failure at highest since 2008
Oct 19 / FT.com
Will This Price Target Increase Help AbbVie (ABBV) Stock Today?
Oct 22 / TheStreet.com
We May Have an Investable Bottom; Smoke Always Clears: Jim Cramer's Best Blogs
Oct 18 / TheStreet.com
Speculating on Achillion's Boom-or-Bust Hep C Drug Study Results
Oct 22 / TheStreet.com
Could This Game-Changing Drug Deliver $10 Billion in Sales Within Its First Year?
Oct 18 / MotleyFool.com
Celgene Corporation's Earnings Preview: Pay Attention to New Kids
Oct 22 / MotleyFool.com
Infinity Pharmaceuticals' Duvelisib Fails in Mid-Stage Study - Analyst Blog
Oct 17 / Zacks.com
AbbVie and HP: corporate writing stinks and the CEO is to blame
Oct 22 / FT.com
Pfizer's AstraZeneca pursuit knocked by Shire deal collapse
Oct 17 / FT.com
AbbVie Drops Shire Deal, Announces Buyback, Ups Dividend - Analyst Blog
Oct 21 / Zacks.com
Gilead's Harvoni Receives Notice of Compliance from Canada - Analyst Blog
Oct 17 / Zacks.com
Avoid the Crowd
Oct 21 / TheStreet.com
AbbVie Inc to Shire: It's Not You, It's My Country
Oct 16 / MotleyFool.com
Notable Analyst Rating Changes 10/21: (GPOR) (ILMN) (POST) Upgraded; (ABBV) (IBM) (BH...
Oct 21 / Investing Channel
Some inversion deals may survive tax changes
Oct 16 / FT.com
#PreMarket Primer: Tuesday, October 21: China's Third Quarter Growth Disappoints
Oct 21 / Benzinga
Shire (SHPG) Shares Crash on Concerns Over AbbVie Buyout - Analyst Blog
Oct 16 / Zacks.com
3 Drugs Critical to Johnson & Johnson's Future
Oct 21 / MotleyFool.com
Deal doers slam the brakes on
Oct 16 / FT.com
European Stocks Rise as Corporate Earnings Overshadow Macro Concerns
Oct 21 / TheStreet.com
3 Reasons AbbVie's Stock Could Rise
Oct 16 / MotleyFool.com
Must Watch Stocks For October 21, 2014
Oct 21 / Benzinga
Stocks: 5 things to know before the open
Oct 16 / CNNMoney.com
AbbVie Unveils $5 Billion Buyback; Blames U.S. For Failed Inversion
Oct 20 / Benzinga
AbbVie drops proposed $54bn Shire deal
Oct 16 / FT.com
Benzinga's M&A Chatter for Monday October 20, 2014
Oct 20 / Benzinga
 $55 billion deal halted by tax dodge crackdown
Oct 15 / CNNMoney.com
Announcement Of Termination Of Proposed AbbVie And Shire Transaction
Oct 20 / Benzinga
Hedge funds face their worst year since 2011
Oct 15 / FT.com
AbbVie hits Treasury as Shire deal dies
Oct 20 / FT.com
AbbVie Reconsiders Shire Acquisition Due to New Tax Rules - Analyst Blog
Oct 15 / Zacks.com
Enanta Pharma Reports Update on Collaboration Deal with AbbVie: Will Not Exercise Opt...
Oct 20 / Benzinga
Biotech Stock Roundup: Gilead Nabs FDA Nod for Combo HCV Drug, Auxilium Accepts Endo ...
Oct 15 / Zacks.com
Will Abbott Labs (ABT) Miss on Earnings This Quarter? - Analyst Blog
Oct 20 / Zacks.com
AbbVie drops B#32bn bombshell on Shire
Oct 15 / FT.com
3 Drugs Stocks Pushing Industry Growth
Oct 20 / TheStreet.com
Johnson & Johnson Earnings: Showing Surprising Weakness
Oct 15 / MotleyFool.com
3 Stocks I'll Buy if the Market Crashes
Oct 20 / MotleyFool.com
Healthcare ETFs in Focus on JNJ Earnings Beat - ETF News And Commentary
Oct 15 / Zacks.com
Cramer Reviews His Top 10 List for a Market Recovery: Boxes Checked!
Oct 20 / TheStreet.com
Should Gilead Sciences, inc. Fear Incoming Competition?
Oct 15 / MotleyFool.com

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.